These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31659091)

  • 1. Evolution of Myeloma Testing in Clinical Chemistry with Mass Spectrometry.
    Murray DL; Willrich MAV
    J Appl Lab Med; 2019 Nov; 4(3):474-476. PubMed ID: 31659091
    [No Abstract]   [Full Text] [Related]  

  • 2. Trade-offs in mass spectrometry.
    Fitzgerald RL; Herold DA; Yergey AL
    Clin Chem; 1997 Jun; 43(6 Pt 1):915. PubMed ID: 9191539
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteoform Analysis to Fulfill Unmet Clinical Needs and Reach Global Standardization of Protein Measurands in Clinical Chemistry Proteomics.
    van der Burgt YEM; Cobbaert CM
    Clin Lab Med; 2018 Sep; 38(3):487-497. PubMed ID: 30115393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for mass spectrometry in clinical chemistry.
    Lawson AM
    Ann Clin Biochem; 1975 Mar; 12(2):51-7. PubMed ID: 15637924
    [No Abstract]   [Full Text] [Related]  

  • 5. Tandem mass spectrometry in the clinical chemistry laboratory.
    Dooley KC
    Clin Biochem; 2003 Sep; 36(6):471-81. PubMed ID: 12951172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic error on Kodak Ektachem: a clue in diagnosis of myeloma.
    Tang M; Sullivan M; Gibson D; Truskolawski C
    Clin Chem; 1994 Jan; 40(1):166-7. PubMed ID: 8287534
    [No Abstract]   [Full Text] [Related]  

  • 7. Preface.
    Makowski GS
    Adv Clin Chem; 2019; 89():xi. PubMed ID: 30797473
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a Targeted Mass-Spectrometry Serum Assay To Quantify M-Protein in the Presence of Therapeutic Monoclonal Antibodies.
    Zajec M; Jacobs JFM; Groenen PJTA; de Kat Angelino CM; Stingl C; Luider TM; De Rijke YB; VanDuijn MM
    J Proteome Res; 2018 Mar; 17(3):1326-1333. PubMed ID: 29424538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of linearity in the clinical laboratory.
    Tholen DW
    Arch Pathol Lab Med; 2004 Oct; 128(10):1078; author reply 1078. PubMed ID: 15387716
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease.
    Thoren KL
    Semin Hematol; 2018 Jan; 55(1):41-43. PubMed ID: 29759153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metrology for metalloproteins--where are we now, where are we heading?
    Swart C
    Anal Bioanal Chem; 2013 Jul; 405(17):5697-723. PubMed ID: 23660692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry and clinical chemistry.
    Hill RE; Whelan DT
    Clin Chim Acta; 1984 Jun; 139(3):231-94. PubMed ID: 6378430
    [No Abstract]   [Full Text] [Related]  

  • 13. Report of the 23rd Asilomar conference on mass spectrometry.
    Rockwood AL; Singh RJ
    J Am Soc Mass Spectrom; 2008 Jul; 19(7):R1-4. PubMed ID: 18485729
    [No Abstract]   [Full Text] [Related]  

  • 14. A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field.
    Naldi M; Giannone FA; Baldassarre M; Domenicali M; Caraceni P; Bernardi M; Bertucci C
    Eur J Mass Spectrom (Chichester); 2013; 19(6):491-6. PubMed ID: 24378467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flame, flameless, and plasma spectroscopy.
    Komaromy-Hiller G
    Anal Chem; 1999 Jun; 71(12):338R-342R. PubMed ID: 10384790
    [No Abstract]   [Full Text] [Related]  

  • 16. [New era of laboratory testing. Topics: I. Generals; 3. Applications of mass spectrometry to laboratory medicine].
    Nomura F
    Nihon Naika Gakkai Zasshi; 2013 Dec; 102(12):3096-102. PubMed ID: 24605556
    [No Abstract]   [Full Text] [Related]  

  • 17. Report from the second European Symposium on Clinical Laboratory and In Vitro Diagnostic Industry. "Physiological reference values: a shared business?".
    Petersen PH
    Clin Chem Lab Med; 2003 Jun; 41(6):825-8. PubMed ID: 12880148
    [No Abstract]   [Full Text] [Related]  

  • 18. [Latest development in mass spectrometry for clinical application].
    Takino M
    Rinsho Byori; 2013 Sep; 61(9):805-15. PubMed ID: 24369593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Validation of Quantitative Mass Spectrometry Assays for Clinical Chemistry Assessments in Animal Models.
    Colangelo JL
    Toxicol Pathol; 2017 Oct; 45(7):977-982. PubMed ID: 29108484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating GFR with ID-MS traceable creatinine assays.
    Lamb EJ; Vickery S; Dalton RN; Stevens PE
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):327. PubMed ID: 16824289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.